1,2-Dihydroxybenzene

Identification

Generic Name
1,2-Dihydroxybenzene
DrugBank Accession Number
DB02232
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 110.1106
Monoisotopic: 110.036779436
Chemical Formula
C6H6O2
Synonyms
Not Available
External IDs
  • C.I.-76500
  • NSC-1573

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UCatechol 1,2-dioxygenaseNot AvailableAcinetobacter sp. (strain ADP1)
UBiphenyl-2,3-diol 1,2-dioxygenaseNot AvailableBurkholderia xenovorans (strain LB400)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
PathwayCategory
Tyrosine MetabolismMetabolic
Tyrosinemia Type IDisease
Disulfiram Action PathwayDrug action
AlkaptonuriaDisease
HawkinsinuriaDisease
Tyrosinemia, Transient, of the NewbornDisease
Dopamine beta-Hydroxylase DeficiencyDisease
Monoamine Oxidase-A Deficiency (MAO-A)Disease
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as catechols. These are compounds containing a 1,2-benzenediol moiety.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Phenols
Sub Class
Benzenediols
Direct Parent
Catechols
Alternative Parents
1-hydroxy-4-unsubstituted benzenoids / 1-hydroxy-2-unsubstituted benzenoids / Benzene and substituted derivatives / Organooxygen compounds / Hydrocarbon derivatives
Substituents
1-hydroxy-2-unsubstituted benzenoid / 1-hydroxy-4-unsubstituted benzenoid / Aromatic homomonocyclic compound / Catechol / Hydrocarbon derivative / Monocyclic benzene moiety / Organic oxygen compound / Organooxygen compound
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
catechols (CHEBI:18135) / a catechol (CATECHOL)
Affected organisms
Not Available

Chemical Identifiers

UNII
LF3AJ089DQ
CAS number
120-80-9
InChI Key
YCIMNLLNPGFGHC-UHFFFAOYSA-N
InChI
InChI=1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H
IUPAC Name
benzene-1,2-diol
SMILES
OC1=CC=CC=C1O

References

General References
Not Available
Human Metabolome Database
HMDB0000957
KEGG Compound
C15571
PubChem Compound
289
PubChem Substance
46507748
ChemSpider
13837760
BindingDB
26188
ChEBI
18135
ChEMBL
CHEMBL280998
ZINC
ZINC000013512214
PDBe Ligand
CAQ
PDB Entries
1dlt / 1knd / 1xep / 2buq / 2buy / 2pum / 3fw4 / 3hhy / 3mi5 / 3o4m
show 16 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)105 °CPhysProp
boiling point (°C)245 °CPhysProp
water solubility4.61E+005 mg/L (at 25 °C)YALKOWSKY,SH & DANNENFELSER,RM (1992)
logP0.88HANSCH,C ET AL. (1995)
logS0.62ADME Research, USCD
pKa9.45 (at 25 °C)SERJEANT,EP & DEMPSEY,B (1979)
Predicted Properties
PropertyValueSource
Water Solubility75.0 mg/mLALOGPS
logP0.74ALOGPS
logP1.37Chemaxon
logS-0.17ALOGPS
pKa (Strongest Acidic)9.34Chemaxon
pKa (Strongest Basic)-6.3Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area40.46 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity30.02 m3·mol-1Chemaxon
Polarizability10.69 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9782
Blood Brain Barrier+0.5
Caco-2 permeable+0.8824
P-glycoprotein substrateNon-substrate0.7207
P-glycoprotein inhibitor INon-inhibitor0.9705
P-glycoprotein inhibitor IINon-inhibitor0.9926
Renal organic cation transporterNon-inhibitor0.9134
CYP450 2C9 substrateNon-substrate0.8247
CYP450 2D6 substrateNon-substrate0.8574
CYP450 3A4 substrateNon-substrate0.7305
CYP450 1A2 substrateNon-inhibitor0.8949
CYP450 2C9 inhibitorNon-inhibitor0.907
CYP450 2D6 inhibitorNon-inhibitor0.9579
CYP450 2C19 inhibitorNon-inhibitor0.9348
CYP450 3A4 inhibitorNon-inhibitor0.957
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7461
Ames testNon AMES toxic0.6674
CarcinogenicityNon-carcinogens0.8689
BiodegradationReady biodegradable0.6877
Rat acute toxicity2.5957 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9322
hERG inhibition (predictor II)Non-inhibitor0.8953
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-0udr-1950000000-16187bb35dcb40c26e78
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-03di-7900000000-8b112b8af75eb2d08676
GC-MS Spectrum - EI-BGC-MSsplash10-03di-8900000000-4e15f35dca47661de590
GC-MS Spectrum - EI-BGC-MSsplash10-03di-9600000000-032a40483dec93738075
GC-MS Spectrum - EI-BGC-MSsplash10-03di-7900000000-83f892852c355a3863e9
GC-MS Spectrum - EI-BGC-MSsplash10-03di-9400000000-90885264baa17f65d954
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0udr-1950000000-16187bb35dcb40c26e78
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0udr-1930000000-24d2e0a8e36245d9e187
Mass Spectrum (Electron Ionization)MSsplash10-03di-9600000000-b8e03f4f3ea89044828e
MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-01ox-9400000000-d59dce8c5e56b026f8b2
MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-014i-9000000000-632cabc9b371835019c1
MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)LC-MS/MSsplash10-02t9-9200000000-ac902cb99981017de3b5
MS/MS Spectrum - EI-B (VARIAN MAT-44) , PositiveLC-MS/MSsplash10-03di-8900000000-95af3d2738de98d27f26
MS/MS Spectrum - EI-B (Unknown) , PositiveLC-MS/MSsplash10-03di-9600000000-032a40483dec93738075
MS/MS Spectrum - EI-B (HITACHI M-80) , PositiveLC-MS/MSsplash10-03di-7900000000-f5cb1c53768e05ca1530
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , NegativeLC-MS/MSsplash10-0a4i-0900000000-c94dab4d218dbb3bb108
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, NegativeLC-MS/MSsplash10-0a4i-1900000000-edd8ba1e77bbb2f76304
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0a4i-0900000000-c94dab4d218dbb3bb108
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0a4i-1900000000-edd8ba1e77bbb2f76304
MS/MS Spectrum - , negativeLC-MS/MSsplash10-0a4i-0900000000-12053747e62e910151ad
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-02u0-9400000000-3eb0a04547f8ae17f2c9
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-0900000000-5e788f94468a06f17fee
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-9000000000-e7b0f2475c865bb3e49c
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-5900000000-de521934f0f1127b2c35
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-9f50ad07befcf8c21661
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0j4l-9000000000-bb7ed7d3c7fdfff406c0
1H NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-115.7439973
predicted
DarkChem Lite v0.1.0
[M-H]-115.7982973
predicted
DarkChem Lite v0.1.0
[M-H]-115.7421973
predicted
DarkChem Lite v0.1.0
[M-H]-115.6715973
predicted
DarkChem Lite v0.1.0
[M-H]-121.64789
predicted
DeepCCS 1.0 (2019)
[M+H]+115.9580973
predicted
DarkChem Lite v0.1.0
[M+H]+117.6789973
predicted
DarkChem Lite v0.1.0
[M+H]+117.5100973
predicted
DarkChem Lite v0.1.0
[M+H]+116.9432973
predicted
DarkChem Lite v0.1.0
[M+H]+123.59653
predicted
DeepCCS 1.0 (2019)
[M+Na]+115.8510973
predicted
DarkChem Lite v0.1.0
[M+Na]+115.6954973
predicted
DarkChem Lite v0.1.0
[M+Na]+115.7769973
predicted
DarkChem Lite v0.1.0
[M+Na]+115.9478973
predicted
DarkChem Lite v0.1.0
[M+Na]+131.60367
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Acinetobacter sp. (strain ADP1)
Pharmacological action
Unknown
General Function
Ferric iron binding
Specific Function
Not Available
Gene Name
catA
Uniprot ID
P07773
Uniprot Name
Catechol 1,2-dioxygenase
Molecular Weight
34347.02 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
Kind
Protein
Organism
Burkholderia xenovorans (strain LB400)
Pharmacological action
Unknown
General Function
Ferrous iron binding
Specific Function
Shows a preference for catechols with groups immediately adjacent to the hydroxyl substituents.
Gene Name
bphC
Uniprot ID
P47228
Uniprot Name
Biphenyl-2,3-diol 1,2-dioxygenase
Molecular Weight
32470.515 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52